How can recombinant adeno-associated virus (rAAV) vector technology be empowered with biofabrication strategies in its translation towards the clinic?

de Ruijter, M.

doi:https://doi.org/10.1016/j.joca.2022.12.005

How can recombinant adeno-associated virus (rAAV) vector technology be empowered with biofabrication strategies in its translation towards the clinic?

DSpace/Manakin Repository

How can recombinant adeno-associated virus (rAAV) vector technology be empowered with biofabrication strategies in its translation towards the clinic?

de Ruijter, M.

(2023) Osteoarthritis and Cartilage, volume 31, issue 4, pp. 421 - 422

(Editorial)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Rheumatology, Biomedical Engineering, Orthopedics and Sports Medicine

DOI: https://doi.org/10.1016/j.joca.2022.12.005

ISSN: 1063-4584

Publisher: W.B. Saunders Ltd

(Peer reviewed)